Pliant Therapeutics
PLRX · NASDAQ
$0.9124+$0.0137 (+1.52%)TodayMarket closed ·
Prev close $0.8987
EPS: actual vs estimate
Beat the estimate in 5 of the last 8 quarters, by 11.0% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.3488 | -$0.36 | −3.2% |
| Q1 FY26 | -$0.3638 | -$0.32 | +12.0% |
| Q4 FY25 | -$0.3856 | -$0.38 | +1.5% |
| Q3 FY25 | -$0.5342 | -$0.43 | +19.5% |
| Q2 FY25 | -$0.7093 | -$0.71 | −0.1% |
| Q1 FY25 | -$0.7388 | -$0.92 | −24.5% |
| Q4 FY24 | -$1.00 | -$0.82 | +18.2% |
| Q3 FY24 | -$0.9886 | -$0.95 | +3.9% |
Earnings calls
- RBC Capital Markets Global Healthcare Conference 2026
- Oppenheimer 36th Annual Healthcare Life Sciences Conference
- Piper Sandler 37th Annual Healthcare Conference
- 43rd Annual J.P. Morgan Healthcare Conference 2025
- Special Call - Pliant Therapeutics, Inc.
- J.P. Morgan 42nd Annual Healthcare Conference 2024
- Special Call - Pliant Therapeutics, Inc.
- Special Call - Pliant Therapeutics, Inc.
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.